沃华医药
(002107)
| 流通市值：41.03亿 | | | 总市值：41.44亿 |
| 流通股本：5.71亿 | | | 总股本：5.77亿 |
| 报告期 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 394,407,753.34 | 392,959,237.05 | 431,483,318.34 | 404,025,624.09 |
| 应收票据及应收账款 | 68,942,996.27 | 66,207,856.98 | 69,976,290.14 | 69,102,264.71 |
| 其中：应收票据 | 1,817,849.38 | 2,993,178.59 | 2,446,864.21 | 2,707,937.99 |
| 应收账款 | 67,125,146.89 | 63,214,678.39 | 67,529,425.93 | 66,394,326.72 |
| 应收款项融资 | 1,695,881.91 | 1,337,364.52 | 2,470,850.79 | 3,496,997.75 |
| 预付款项 | 2,353,770.45 | 3,164,811.6 | 2,983,407.61 | 3,839,211.85 |
| 其他应收款合计 | 1,321,316.88 | 2,173,249.71 | 1,683,658.87 | 1,815,635.33 |
| 存货 | 93,462,435.78 | 84,821,049.64 | 101,298,840.45 | 98,562,497.96 |
| 其他流动资产 | 4,586,782.04 | 4,599,161.85 | 4,760,440.04 | 4,918,796.93 |
| 流动资产合计 | 566,770,936.67 | 555,262,731.35 | 614,656,806.24 | 585,761,028.62 |
| 非流动资产: | | | | |
| 投资性房地产 | 16,932,684.66 | 17,113,373.01 | 17,294,061.36 | 17,474,749.71 |
| 固定资产 | 325,324,986.26 | 332,374,093.07 | 339,479,026.23 | 346,575,022.11 |
| 使用权资产 | 1,124,012.78 | 1,357,173.47 | 1,589,862.62 | 1,822,551.77 |
| 无形资产 | 34,339,715.21 | 34,639,170.61 | 34,938,625.66 | 35,244,721.39 |
| 商誉 | 32,508,664.53 | 32,508,664.53 | 32,508,664.53 | 32,508,664.53 |
| 递延所得税资产 | 355,467.09 | 418,249.48 | 377,525.82 | 381,857.21 |
| 其他非流动资产 | 13,500 | 20,690 | 10,000 | 10,000 |
| 非流动资产合计 | 410,599,030.53 | 418,431,414.17 | 426,197,766.22 | 434,017,566.72 |
| 资产总计 | 977,369,967.2 | 973,694,145.52 | 1,040,854,572.46 | 1,019,778,595.34 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 38,751,277.57 | 34,188,414.73 | 50,754,116.66 | 46,088,085.67 |
| 应付账款 | 38,751,277.57 | 34,188,414.73 | 50,754,116.66 | 46,088,085.67 |
| 预收款项 | 167,177.9 | - | - | - |
| 合同负债 | 5,276,684.48 | 2,608,388.98 | 2,421,581.92 | 2,364,396.69 |
| 应付职工薪酬 | 8,841,718.15 | 7,032,787.88 | 7,520,734.01 | 7,301,744.32 |
| 应交税费 | 13,311,512.7 | 17,453,183.57 | 12,568,613.01 | 13,710,316.88 |
| 其他应付款合计 | 37,545,758.63 | 38,518,317.65 | 40,613,301.04 | 35,986,809.46 |
| 一年内到期的非流动负债 | 920,311.6 | 911,849.87 | 903,388.13 | 895,018.37 |
| 其他流动负债 | 135,916,637.69 | 146,959,178.99 | 147,529,059.32 | 152,675,135.81 |
| 流动负债合计 | 240,731,078.72 | 247,672,121.67 | 262,310,794.09 | 259,021,507.2 |
| 非流动负债: | | | | |
| 租赁负债 | 233,380.88 | 513,331.6 | 789,715.59 | 1,063,684.4 |
| 长期应付职工薪酬 | 64,733.9 | 90,032.5 | 121,788.49 | 167,031.76 |
| 递延收益 | 11,737,747.01 | 12,766,836.02 | 13,499,465.83 | 14,232,481 |
| 递延所得税负债 | 3,702,932.64 | 3,932,184.98 | 3,940,969.81 | 4,167,510.92 |
| 非流动负债合计 | 15,738,794.43 | 17,302,385.1 | 18,351,939.72 | 19,630,708.08 |
| 负债合计 | 256,469,873.15 | 264,974,506.77 | 280,662,733.81 | 278,652,215.28 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 577,209,600 | 577,209,600 | 577,209,600 | 577,209,600 |
| 盈余公积 | 61,947,866.71 | 46,272,148.97 | 46,272,148.97 | 46,272,148.97 |
| 未分配利润 | 84,660,979.34 | 68,616,396.78 | 118,562,949.38 | 96,746,369.31 |
| 归属于母公司股东权益合计 | 723,818,446.05 | 692,098,145.75 | 742,044,698.35 | 720,228,118.28 |
| 少数股东权益 | -2,918,352 | 16,621,493 | 18,147,140.3 | 20,898,261.78 |
| 股东权益合计 | 720,900,094.05 | 708,719,638.75 | 760,191,838.65 | 741,126,380.06 |
| 负债和股东权益合计 | 977,369,967.2 | 973,694,145.52 | 1,040,854,572.46 | 1,019,778,595.34 |
| 公告日期 | 2026-01-20 | 2025-10-18 | 2025-07-22 | 2025-04-26 |
| 审计意见(境内) | 标准无保留意见 | | | |